Jason A. Chesney, MD, PhD

Professor of Medicine
University of Louisville, Louisville, KY, USA, United States

Presentation(s):

• 60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers

  Friday, March 24, 2023
  10:54 AM – 11:04 AM

  Disclosure information not submitted.

• 64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study

  Friday, March 24, 2023
  11:34 AM – 11:44 AM

  Disclosure information not submitted.